It is becoming clear that enzymes have dynamic structures that respond to changes in their environment (1-3). The presence of substrate and cofactors, the identities and oxidation states of ligands and metal centers, all can have a dramatic effect on the compactness, conformation, and oligomerization state of an enzyme. For membrane-bound or membrane-associated enzymes, how the enzyme interacts with the lipid bilayer is yet another variable that affects overall protein structure and stability. There is a paucity of structures for intact membrane proteins in the Protein Data Bank (PDB), making it difficult to determine to what extent membrane association modifies protein conformations. Although many structures have been obtained using versions of membrane proteins with their membranebinding domains removed, these are not particularly helpful for understanding proteinbilayer interactions. In PNAS, Monk et al.
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pull back the curtain a bit on this important question (4) .
In their paper, Monk et al. describe several crystallographic structures of lanosterol 14α demethylase (CYP51) from Saccharomyces cerevisiae. The enzyme consists of three domains: a catalytic C-terminal cytochrome P450 (CYP) linked via an intermediate transmembrane helix (TMH) to an N-terminal amphipathic (AH) helix that resides in vivo on the inner side of the ER membrane. A remarkable feature of the described structure is the clear segregation of the catalytic domains from the TMH domains within the crystal lattice. The TMH domains are well ordered, and there is a high degree of interaction between the AH domains and symmetry-related CYP domains on the opposite sides of the TMH region. Specific interactions between residues on the TMH domain and the CYP domain constrain their relative orientations, resulting in a spacing of 33 Å between CYP domains separated by the TMH domains, a typical value for lipid bilayer thickness (Fig. 1) . Although no ordered bilayer components are detected (the protein crystallizations were performed using a nonionic detergent), the inference is obvious that the crystallographic structures accurately capture the relative arrangement of the three subunits of the bitopic (single TMH) structure.
These results stand out for several reasons. First, this is (surprisingly!) the only complete structure of a bitopic membrane protein deposited in the PDB, and it provides some important general insights into how enzymes are constrained at membrane surfaces. The degree to which the specific interactions between the TMH and the CYP domains appear to orient and control the interface between the lipid bilayer and the CYP is unexpected: rather than a loose anchor, the TMH provides a relatively rigid dock for the catalytic domain in the bilayer (Fig. 2) . Like a boat tied to a single stanchion, a series of hydrogen bonding and polar interactions between the TMH and the CYP fixes the position of the active site entrance in the lipid bilayer by holding the "prow" of the CYP in place. At the same time, the arrangement should be entropically favorable, as it permits a fair amount of lateral motion on the part of the CYP in the plane of the bilayer. That the constrained region of the CYP is indeed the entrance (vestibule) to the active site is confirmed by a structure with a bound extended conformation inhibitor: The inhibitor extends from the heme iron (to which it is linked by a dative covalent bond) to a helical bend close to the TMH-CYP interaction site. Furthermore, electron density consistent with a lanosterol-sized molecule is observed in a secondary vestibule site located on the other side of the TMH-CYP interaction locus, in a position that is expected to be submerged in the lipid bilayer. As such, the structures described by Monk et al. provide evidence for substrate access to the CYP active site directly from the lipid bilayer. A single data point, perhaps, but it opens up a different way of considering such interactions in other bitopic membrane proteins.
For those of us who work with cytochromes P450, the results of Monk et al. are exciting for other reasons as well. The cytochrome P450 monooxygenases comprise one of the oldest and most widespread enzyme superfamilies. More than 100,000 putative P450 genes have been deposited in GenBank to date, and representatives of the superfamily have been identified in every kingdom and phylum of life. P450s typically activate molecular oxygen (O 2 ) for reaction with unactivated C-H and/or C-C bonds, resulting in the hydroxylation or epoxidation of the target substrates. Substrates range in size from tiny (terpenes and small alkanes) to large steroid and macrocyclic antibiotic precursors. P450-catalyzed reactions are often quite specific in terms of substrate selectivity and regio-and stereochemistry of the oxidations catalyzed. However, despite the vast sequence space covered by the P450 superfamily and the bewildering range of possible substrate/product combinations, the P450 fold is both unique and highly conserved (5) . Given that the chemistry catalyzed by P450 is inherently dangerous to the host organism (think of a plumber using a brazing torch in an old wooden house), it appears that the P450 fold was settled on very early in evolution as a way of activating molecular oxygen safely and efficiently. As such, there are features of the P450 structure and active site that are strictly conserved, regardless of the size of substrate. All P450s contain a heme Fe axially ligated by a conserved cysteine thiolate on the proximal side of the enzyme, with the opposite axial site (within the active site of the enzyme, on the distal side of the heme) alternatively either vacant or occupied by water, molecular oxygen, or other small ligand. One wall of the distal cavity is formed by a long helix (I), which is usually slightly kinked at the distal cavity. This kink is thought to accommodate the bound O 2 (6) . The active site cavity lining is hydrophobic, and the size of the active site is modulated by perturbations in the surrounding secondary structural features, particularly the F, F′, G, and B′ helices (Fig. 1) .
Although prokaryotic P450s that catalyze the oxidation of small hydrophobic molecules are often soluble enzymes, all identified eukaryotic P450s are membrane bound. Until now, the crystallographic structures of eukaryotic P450s have been obtained using truncated or otherwise modified enzymes (5) or crystallized with the membrane binding domain disordered (7) . The substrates of eukaryotic P450s are often hydrophobic and lipid soluble, so it has long been assumed that entry to the active sites of such enzymes are via the membrane, where both substrate and product will be soluble. However, the current structures provide previously unidentified structural evidence to support this assumption.
Another question into which Monk et al. provide some insight with their current work is the extent to which interaction between the CYP domain and lipid bilayer influences the structure of the active site and vestibule. Some eukaryotic P450s show a remarkable degree of plasticity in their active sites, with different crystallographic forms exhibiting different arrangements of the residues that make up the B′, F, and G helices (8, 9) . As the F and G helices are presumed to interact with the lipid bilayer, there is some concern that the observed differences are artifacts of crystallization conditions rather than conformations likely to be observed in vivo. Comparison of the inhibitor-bound structure of Monk et al. with that of a homologous lanosterol hydroxylase from Trypanosoma cruzi (10) shows significant differences between the structure of the presumed membrane-embedded regions (Fig. 3) . The T. cruzi enzyme was modified by removal of the first 30 residues and therefore cannot form the CYP-TMH interactions that direct the organization of the enzyme in the lipid bilayer. Given that the TMH orientation is itself determined by the width of the lipid bilayer in vivo, it is reasonable to conclude that the membrane plays at least an indirect role in determining the shape and size of the CYP51 active site. (4) (PDB code 4K0F) in magenta and that of the truncated T. cruzi enzyme (10) (PDB code 3K1O) in cyan. The region interacting with the TMH in 4K0F (near the A helix and β1 sheet) is shown for both enzymes. The loop connecting the F and G helices in 3K1O is disordered in the T. cruzi enzyme between Pro-216 and Leu-221, as is the loop following the G helix, between Lys-254 and Asn-257. The structure is ordered in both places in the 4K0F structure.
